108 related articles for article (PubMed ID: 33620089)
1. CKLF and IL1B transcript levels at diagnosis are predictive of relapse in children with pre-B-cell acute lymphoblastic leukaemia.
Fitter S; Bradey AL; Kok CH; Noll JE; Wilczek VJ; Venn NC; Law T; Paisitkriangkrai S; Story C; Saunders L; Dalla Pozza L; Marshall GM; White DL; Sutton R; Zannettino ACW; Revesz T
Br J Haematol; 2021 Apr; 193(1):171-175. PubMed ID: 33620089
[TBL] [Abstract][Full Text] [Related]
2. A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children.
Sutton R; Venn NC; Law T; Boer JM; Trahair TN; Ng A; Den Boer ML; Dissanayake A; Giles JE; Dalzell P; Mayoh C; Barbaric D; Revesz T; Alvaro F; Pieters R; Haber M; Norris MD; Schrappe M; Dalla Pozza L; Marshall GM
Br J Haematol; 2018 Feb; 180(4):550-562. PubMed ID: 29194562
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
4. CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia.
van Zutven LJ; van Drunen E; de Bont JM; Wattel MM; Den Boer ML; Pieters R; Hagemeijer A; Slater RM; Beverloo HB
Leukemia; 2005 Jul; 19(7):1281-4. PubMed ID: 15843818
[No Abstract] [Full Text] [Related]
5. New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemia.
van der Velden VH; de Launaij D; de Vries JF; de Haas V; Sonneveld E; Voerman JS; de Bie M; Revesz T; Avigad S; Yeoh AE; Swagemakers SM; Eckert C; Pieters R; van Dongen JJ
Br J Haematol; 2016 Mar; 172(5):769-81. PubMed ID: 26898195
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide DNA methylation profiling predicts relapse in childhood B-cell acute lymphoblastic leukaemia.
Sandoval J; Heyn H; Méndez-González J; Gomez A; Moran S; Baiget M; Melo M; Badell I; Nomdedéu JF; Esteller M
Br J Haematol; 2013 Feb; 160(3):406-9. PubMed ID: 23110451
[No Abstract] [Full Text] [Related]
7. C-myc protein expression in B-cell acute lymphoblastic leukemia, prognostic significance?
Allen A; Gill K; Hoehn D; Sulis M; Bhagat G; Alobeid B
Leuk Res; 2014 Sep; 38(9):1061-6. PubMed ID: 25060305
[TBL] [Abstract][Full Text] [Related]
8. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013.
Olsson L; Ivanov Öfverholm I; Norén-Nyström U; Zachariadis V; Nordlund J; Sjögren H; Golovleva I; Nordgren A; Paulsson K; Heyman M; Barbany G; Johansson B
Br J Haematol; 2015 Sep; 170(6):847-58. PubMed ID: 26018335
[TBL] [Abstract][Full Text] [Related]
9. Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia.
Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; Behrendt H; Slater RM; von dem Borne AE; van der Schoot CE
Leukemia; 1995 Oct; 9(10):1726-34. PubMed ID: 7564517
[TBL] [Abstract][Full Text] [Related]
10. [Clinical research on clearance of leukemic cell during induction of remission therapy in children with precursor B cell acute lymphoblastic leukemia].
Yi ZG; Cui L; Gao C; Jin M; Zhang RD; Li ZG; Wu MY
Zhonghua Er Ke Za Zhi; 2011 Mar; 49(3):170-4. PubMed ID: 21575363
[TBL] [Abstract][Full Text] [Related]
11. Aneuploidy in children with relapsed B-cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse.
Groeneveld-Krentz S; Schroeder MP; Reiter M; Pogodzinski MJ; Pimentel-Gutiérrez HJ; Vagkopoulou R; Hof J; Chen-Santel C; Nebral K; Bradtke J; Türkmen S; Baldus CD; Gattenlöhner S; Haas OA; von Stackelberg A; Karawajew L; Eckert C; Kirschner-Schwabe R
Br J Haematol; 2019 Apr; 185(2):266-283. PubMed ID: 30714092
[TBL] [Abstract][Full Text] [Related]
12. ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.
Hirabayashi S; Ohki K; Nakabayashi K; Ichikawa H; Momozawa Y; Okamura K; Yaguchi A; Terada K; Saito Y; Yoshimi A; Ogata-Kawata H; Sakamoto H; Kato M; Fujimura J; Hino M; Kinoshita A; Kakuda H; Kurosawa H; Kato K; Kajiwara R; Moriwaki K; Morimoto T; Nakamura K; Noguchi Y; Osumi T; Sakashita K; Takita J; Yuza Y; Matsuda K; Yoshida T; Matsumoto K; Hata K; Kubo M; Matsubara Y; Fukushima T; Koh K; Manabe A; Ohara A; Kiyokawa N;
Haematologica; 2017 Jan; 102(1):118-129. PubMed ID: 27634205
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of haploidentical hematopoietic stem cell transplantation in non-infant children with t(v;11q23)/MLL-rearranged B-cell acute lymphoblastic leukemia.
Bai L; Cheng YF; Lu AD; Suo P; Wang Y; Zuo YX; Yan CH; Wu J; Jia YP; Sun YQ; Chen YH; Chen H; Liu KY; Han W; Xu LP; Wang JB; Tang XF; Chen HR; Zhang LP; Huang XJ
Leuk Res; 2020 Apr; 91():106333. PubMed ID: 32109757
[TBL] [Abstract][Full Text] [Related]
14. PRAME overexpression predicted good outcome in pediatric B-cell acute lymphoblastic leukemia patients receiving chemotherapy.
Zhang YH; Lu AD; Yang L; Li LD; Chen WM; Long LY; Zhang LP; Qin YZ
Leuk Res; 2017 Jan; 52():43-49. PubMed ID: 27875783
[TBL] [Abstract][Full Text] [Related]
15. Gene copy number alteration profile and its clinical correlation in B-cell acute lymphoblastic leukemia.
Gupta SK; Bakhshi S; Kumar L; Kamal VK; Kumar R
Leuk Lymphoma; 2017 Feb; 58(2):333-342. PubMed ID: 27339065
[TBL] [Abstract][Full Text] [Related]
16. Deletion of CDKN2A/B is associated with inferior relapse free survival in pediatric B cell acute lymphoblastic leukemia.
Kathiravan M; Singh M; Bhatia P; Trehan A; Varma N; Sachdeva MS; Bansal D; Jain R; Naseem S
Leuk Lymphoma; 2019 Feb; 60(2):433-441. PubMed ID: 29966470
[TBL] [Abstract][Full Text] [Related]
17. miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia.
Avigad S; Verly IR; Lebel A; Kordi O; Shichrur K; Ohali A; Hameiri-Grossman M; Kaspers GJ; Cloos J; Fronkova E; Trka J; Luria D; Kodman Y; Mirsky H; Gaash D; Jeison M; Avrahami G; Elitzur S; Gilad G; Stark B; Yaniv I
Genes Chromosomes Cancer; 2016 Apr; 55(4):328-39. PubMed ID: 26684414
[TBL] [Abstract][Full Text] [Related]
18. CD99 expression is strongly associated with clinical outcome in children with B-cell precursor acute lymphoblastic leukaemia.
Chen D; Camponeschi A; Wu Q; Gerasimcik N; Li H; Shen X; Tan Y; Sjögren H; Nordlund J; Lönnerholm G; Abrahamsson J; Fogelstrand L; Mårtensson IL
Br J Haematol; 2019 Feb; 184(3):418-423. PubMed ID: 30484860
[TBL] [Abstract][Full Text] [Related]
19. Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse.
Good Z; Sarno J; Jager A; Samusik N; Aghaeepour N; Simonds EF; White L; Lacayo NJ; Fantl WJ; Fazio G; Gaipa G; Biondi A; Tibshirani R; Bendall SC; Nolan GP; Davis KL
Nat Med; 2018 May; 24(4):474-483. PubMed ID: 29505032
[TBL] [Abstract][Full Text] [Related]
20. CD38+ CD58- is an independent adverse prognostic factor in paediatric Philadelphia chromosome negative B cell acute lymphoblastic leukaemia patients.
Li XM; Zhang LP; Wang YZ; Lu AD; Chang Y; Zhu HH; Qin YZ; Lai YY; Kong Y; Huang XJ; Liu YR
Leuk Res; 2016 Apr; 43():33-8. PubMed ID: 26930456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
